Preclinical efficacy of TGF-beta receptor I kinase inhibitor, galunisertib, in myelofibrosis Meeting Abstract


Authors: Yue, L.; Bartenstein, M.; Zhao, W.; Ho, W. T.; Zhang, L.; Rapaport, F.; Levine, R. L.; Zhao, Z. J.; Verma, A.; Epling-Burnette, P. K.
Abstract Title: Preclinical efficacy of TGF-beta receptor I kinase inhibitor, galunisertib, in myelofibrosis
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368019002040
PROVIDER: wos
DOI: 10.1182/blood.V126.23.603.603
Notes: Meeting Abstract: 603 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine